Evofem Biosciences, Inc. (NASDAQ:EVFM) has a beta value of 0.4 and has seen 570,384 shares traded in the last trading session. The company, currently valued at $204.83 Million, closed the last trade at $2.52 per share which meant it lost -$0.04 on the day or -1.56% during that session. The EVFM stock price is -197.62% off its 52-week high price of $7.5 and 24.21% above the 52-week low of $1.91. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.01 Million shares traded. The 3-month trading volume is 4.56 Million shares.
The consensus among analysts is that Evofem Biosciences, Inc. (EVFM) is an Overweight stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 4 have rated it as a Hold, with 3 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.44.
Evofem Biosciences, Inc. (NASDAQ:EVFM) trade information
Despite being -1.56% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Oct 19 when the EVFM stock price touched $2.93-1 or saw a rise of 13.99%. Year-to-date, Evofem Biosciences, Inc. shares have moved -59.16%, while the 5-day performance has seen it change -11.89%. Over the past 30 days, the shares of Evofem Biosciences, Inc. (NASDAQ:EVFM) have changed 18.87%. Short interest in the company has seen 11.8 Million shares shorted with days to cover at 2.59.
Wall Street analysts have a consensus price target for the stock at $7, which means that the shares’ value could jump 177.78% from current levels. The projected low price target is $3 while the price target rests at a high of $11. In that case, then, we find that the current price level is +336.51% off the targeted high while a plunge would see the stock lose 19.05% from current levels.
Evofem Biosciences, Inc. (EVFM) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +42.7% over the past 5 years. Earnings growth for 2020 is a modest +65.4%.
Evofem Biosciences, Inc. (NASDAQ:EVFM)’s Major holders
Insiders own 30.97% of the company shares, while shares held by institutions stand at 75.27% with a share float percentage of 109.04%. Investors are also buoyed by the number of investors in a company, with Evofem Biosciences, Inc. having a total of 68 institutions that hold shares in the company. The top two institutional holders are Invesco Ltd. with over 12.67 Million shares worth more than $35.86 Million. As of June 29, 2020, Invesco Ltd. held 15.59% of shares outstanding.
The other major institutional holder is Morgan Stanley, with the holding of over 3.05 Million shares as of June 29, 2020. The firm’s total holdings are worth over $8.64 Million and represent 3.76% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Heartland Value Fund. As of June 29, 2020, the former fund manager holds about 2.22% shares in the company for having 1802858 shares of worth $5.1 Million while later fund manager owns 1.5 Million shares of worth $4.25 Million as of June 29, 2020, which makes it owner of about 1.85% of company’s outstanding stock.